Swallowing & Speech Production in Parkinson's Disease
Ann Neurol 19:238-287, Robbins,J.,et al, 1986
Dopamine D2 Receptor Density Remains Constant in Treated Parkinson's Disease
Ann Neurol 19:487-492, Guttman,M.,et al, 1986
Fetal Neuronal Grafts in Monkeys Given Methylphenyltetrahydropyridine
Lancet 1:1125-1127, Redmond,D.E.,et al, 1986
Clinicopath. Conference
Pick's Disease of Brain, with Frontal Lobar Atrophy, Degen of Basal Ganglia, Case 16-1986, NEJM 314:, 101-,1986., 1986
Hypesthetic-Ataxic-Hemiparesis in Thalamic Hemorrhage
Stroke 17:49-51, Verma,A.K.&Maheshwari,M.C., 1986
Disappearance of Parkinsonian Signs after Spontaneous Vascular"Thalamotomy"
Arch Neurol 43:815-817, Dubois,B.,et al, 1986
Parkinson's Disease
BMJ 293:379-382, Quinn,N.P.&Husain,F.A., 1986
Magnetic Resonance Imaging of the Midbrain in Parkinson's Disease
Ann Neurol 20:744-747, Duguid,J.R.,et al, 1986
Smoking & Parkinson's Disease, Search for a Dose-Response Relationship
Arch Neurol 43:774-778, Golve,L.I.,et al, 1986
Cigarette Smoking & Parkinson's Disease
Neurol 36:1490-1496, Baron,J.A., 1986
Mental Disorders in Parkinson's Disease
RI Med Jour 69:323-326, Rafal,R., 1986
Brain Dopamine Metabolism in Patients with Parkinson's Disease Measured with Positron Emission Tomography
JNNP 49:853-860, Leenders,K.L.,et al, 1986
A Case of Parkinsonism Following Striatal Lacunar Infarction
JNNP 49:1087-1088, Friedman,A.,et al, 1986
Pathologic Correlates of Dementia in Parkinson's Disease
Arch Neurol 43:991-995, Chui,H.C.,et al, 1986
Paraquat & Parkinson's Disease
Neurol 36:1147, Koller,W.C., 1986
The Neuroleptic Malignant Syndrome:Agent and Host Interaction
Acta Psychiatr Scand 73:337-347, Shaley,A.&Munitz,H., 1986
Intraaortic Balloon Pumping 1967 through 1982:Analysis of Complications in 733 Patients
Am J Cardiol 57:976-983, Kantrowitz,A.,et al, 1986
Vertigo and Dizziness
In Diseases of the Nervous System, Asbury, A. K. , et al, W B Saunders, p. 561, Brandt,T., 1986
Parkinsonism Following Dystonia in Three Patients
Movement Disorders 1:151-157, Katchen,M.&Duvoisin,R.C., 1986
Dystonia-Parkinson Syndrome:Differential Effects of Levodopa and Dopamine Agonists
Clin Neuropharmacol 9:298-302, Klawans,H.L.&Paleologos,N., 1986
Dystonia in Untreated Parkinsonism
Clin Neuropharmacol 9:293-297, LeWitt,P.A.,et al, 1986
Prevalence of Parkinson's Disease in the Biracial Population of Copiah County, Mississippi
Neurol 35:841-845, Schoenberg,B.S.,et al, 1985
Giant Cell Arteritis Associated with Mononeuritis Multiplex & Complement-Activating 19S IgM Rheumatoid Factor
Am J Med 79:495-500, Feigal,D.W.,et al, 1985
Radial Compression Neuropathy in Advanced Parkinson's Disease
Arch Neurol 42:695-696, Preston,D.N.,et al, 1985
Severe Compression Neuropathy Following Sudden Onset of Parkinsonian Immobility
Arch Neurol 42:720, Kurlan,R.,et al, 1985
Association Between Essential Tremor & Parkinson's Disease
Ann Neurol 17:329-333, Gereghty,J.J.,et al, 1985
Low Cancer Rates Among Patients with Parkinson's Disease
Ann Neurol 17:505-509, Jansson,B.,et al, 1985
The Clinical Syndrome of Striatal Dopamine Deficiency, Parkinsonism Induced by MPTP
NEJM 312:1418-1421, Burns,R.S.,et al, 1985
Permanent Human Parkinsonism Due to 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine (MPTP) :Seven Cases
Neurol 35:949-956, Ballard,P.A.,et al, 1985
Treatment of Progressive Supranuclear Palsy with Tricyclic Antidepressants
Neurol 35:1189-1193, Newman,G.C., 1985
Acute Exacerbation of Parkinson's Disease with Sulindac
Ann Neurol 17:104-105, Sandyk,R.,et al, 1985
Late-Onset Hallervorden-Spatz Disease Presenting as Familial Parkinsonism
Neurol 35:227-234, Jankovic,J.,et al, 1985
Extrapyramidal Reactions with Metoclopramide
BMJ 291:930-932, Bateman,D.N.,et al, 1985
Olfactory Dysfunction in Alzheimer's Disease & Parkinson's Disease
Am J Psychiatry 142:781-782, Serby,M.,et al, 1985
Cyanide-Induced Parkinsonism:A Clinicopathologic Report
Neurol 35:921-925, Uitti,R.J.,et al, 1985
"Apraxia"of Eyelid Opening:An Involuntary Levator Inhibition
Neurol 35:423-427, Lepore,F.E.,et al, 1985
Low Dosages of Bromocriptine Added to Levodopa in Parkinson's Disease
Neurol 35:199-206, Maier,M.M.,et al, 1985
The Nucleus Basalis of Meynert in Neurological Disease:A Quantitative Morphological Study
Ann Neurol 17:163-170, Rogers,J.D.,et al, 1985
Reversible Parkinsonism Related to Meperidine
NEJM 312:509, Lieberman,A.N.,et al, 1985
Development of Malignant Melanoma after Levodopa Therapy for Parkinson's Disease, Report of Case & Review
Am J Med 79:119-121, Kochar,A.S., 1985
Levodopa & Melanoma:Three Cases & Review of Literature
JNNP 48:585-588, Rampen,F.H.J., 1985
Low-Dose Bromocriptine Therapy in Parkinson's Disease
Arch Neurol 42:586-588, Pfeiffer,R.F.,et al, 1985
Reappraisal of Temporary Levodopa Withdrawal ("Drug Holiday") in Parkinson's Disease
NEJM 313:724-728, Mayeux,R.,et al, 1985
"Drug Holiday"in the Treatment of Parkinson's Disease, A Brief Review
Arch Int Med 145:913-915, Friedman,J.H., 1985
Mesulergin (CU32-085) in the Treatment of Parkinson's Disease
Ann Neurol 17:334-336, Pfeiffer,R.F.,et al, 1985
Reversal of Sleep Disturbance in Parkinson's Disease by Antiparkinsonian Therapy:A Preliminary Study
Neurol 35:527-532, Askenasy,J.J.M.,et al, 1985
Lacunar Syndrome Due to Intracerebral Hemorrhage
Stroke 16:454-459, Mori,E.,et al, 1985
Long-Term Study of Pergolide in Parkinson's Disease
Neurol 35:296-299, Jankovic,J., 1985
Placebo-Controlled Study of Mesulergine in Parkinson's Disease
Neurol 35:161-165, Jankovic,J.,et al, 1985
Diagnosis & Treatment of Lumbosacral Plexopathies in Patients with Cancer
Arch Neurol 41:1282-1285, Pettigrew,L.C.,et al, 1984